Is BHRT FDA Approved? What Every Patient Needs to Know Before Starting Hormone Therapy

If you’ve spent any time researching bioidentical hormone replacement therapy, you’ve probably hit a wall of contradictory information — and one question keeps surfacing: is BHRT FDA approved? It’s a fair question, and the honest answer is more nuanced than a simple yes or no. Some bioidentical hormone products carry full FDA approval. Others — particularly the custom-compounded formulas many integrative practitioners prescribe — do not. Understanding that distinction is not just a regulatory footnote. It directly affects how you evaluate your options, talk to your provider, and protect your health.

This post breaks down exactly what the FDA’s stance on bioidentical hormones actually means, what it doesn’t mean, and how to use this information to make smarter, more confident decisions.

Understanding BHRT FDA Approval: The Answer Is More Complicated Than You Think

The phrase “bioidentical hormone replacement therapy” covers a wide range of products that share one defining characteristic: the hormones they contain are molecularly identical to the hormones your body produces naturally. But that shared molecular identity does not mean all BHRT products are regulated the same way.

Here is where the critical distinction lies. There are two broad categories of BHRT:

1. FDA-approved commercial bioidentical hormone products. These are manufactured drugs that have gone through the FDA’s standard drug approval process — meaning clinical trials, manufacturing inspections, labeling reviews, and post-market surveillance. Estradiol patches, gels, sprays, and vaginal preparations, along with oral micronized progesterone (Prometrium), all fall into this category. They contain bioidentical hormones and they are FDA-approved.

2. Custom-compounded BHRT. These are formulations prepared by a licensed compounding pharmacy to fill an individual patient’s prescription. A provider might prescribe a specific dose of estriol, estradiol, and progesterone in a topical cream, for example — a combination not available as a commercial product. Compounding pharmacies are regulated by state boards of pharmacy and, in some cases, by the FDA under specific frameworks, but the individual compounded preparations themselves have not been through the drug approval process.

So when someone asks “is BHRT FDA approved,” the accurate answer is: some of it is, and some of it isn’t — and the difference matters more than most people realize.

What FDA Approval Actually Means (And What It Doesn’t)

FDA approval is a process, not a verdict on whether a medication is “good” or “bad.” When a drug receives FDA approval, it means the manufacturer has demonstrated — through structured clinical trials — that the product is safe and effective for its intended use, that it is manufactured consistently to a defined standard, and that its labeling accurately reflects the evidence.

For patients, this translates into several concrete protections. You can be reasonably confident that an FDA-approved estradiol patch delivers the dose printed on the label, that the manufacturing facility has been inspected, and that the product’s known risks are disclosed in standardized language.

What FDA approval does not mean is that a medication is risk-free or superior to every alternative. FDA-approved hormone therapies carry their own risk profiles, and those risks are real — particularly for certain patient populations. The FDA approval process evaluates whether a product’s benefits outweigh its risks for a defined population under defined conditions. It is a threshold, not a seal of perfection.

It also does not mean that compounded options are automatically dangerous or illegitimate. Compounding has a long and legitimate history in pharmacy, and there are valid clinical reasons why some patients need formulations that commercial products cannot provide.

For a clear-eyed look at what the evidence actually says about hormone therapy safety more broadly, see our deep dive into BHRT Safety: What the Research Actually Shows.

The Regulatory Landscape for Compounded BHRT

Compounded BHRT occupies a more complex regulatory space. Compounding pharmacies operate under state pharmacy board oversight, which varies significantly from state to state. At the federal level, the FDA has authority over certain compounding activities — particularly for pharmacies that compound large volumes of standardized preparations — under the Drug Quality and Security Act of 2013.

The FDA has consistently expressed concern about specific marketing and safety practices in the compounded BHRT space. In guidance documents and warning letters, the agency has flagged several issues:

• Unsupported health claims. Some compounding providers have marketed formulations — including preparations containing estriol — as safer than FDA-approved options without clinical evidence to support those claims. The FDA has stated that estriol is not an FDA-approved drug and that safety claims for estriol-containing compounds are not supported by adequate evidence.
• Inconsistent potency. Because compounded preparations are not subject to the same manufacturing standards as commercial drugs, potency and sterility can vary between batches and between pharmacies.
• Hormone testing claims. Some practitioners use salivary hormone testing to guide BHRT dosing. The FDA and major endocrinology organizations have noted that salivary testing is not a validated method for calibrating hormone therapy doses.

None of this means every compounding pharmacy is operating poorly. Many are highly rigorous. Patients who choose compounded BHRT are generally advised to seek pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB), which holds member pharmacies to higher standards of quality and testing than state licensure alone requires.

To separate marketing myths from medical reality on this topic, our post on BHRT Myths Debunked: Separating Fact from Fiction covers many of the unsupported claims that circulate in this space.

Which Bioidentical Hormone Products Are FDA-Approved?

This is where patients are often surprised. Many people assume that “bioidentical” and “FDA-approved” are mutually exclusive — that the mainstream medical establishment only endorses synthetic hormones and that bioidentical options exist only in the compounding world. That is not accurate.

The following product categories contain bioidentical hormones and carry full FDA approval:

Estradiol products:

• Transdermal patches (Vivelle-Dot, Climara, Minivelle, and others)
• Topical gels (EstroGel, Divigel, Elestrin)
• Topical spray (Evamist)
• Vaginal ring (Estring, Femring)
• Vaginal cream (Estrace)
• Vaginal tablets/inserts (Vagifem, Yuvafem)
• Oral tablets (Estrace — though oral delivery is generally considered less favorable than transdermal due to first-pass liver metabolism)

Progesterone:

• Oral micronized progesterone (Prometrium) — this is bioidentical progesterone, not a synthetic progestin like medroxyprogesterone acetate (MPA)

Testosterone (for men):

• AndroGel, Testim, Axiron, and others — all contain bioidentical testosterone and are FDA-approved for hypogonadism in men

Important note for women: No testosterone product is currently FDA-approved for use in women, though testosterone is prescribed off-label for women by many clinicians, often via compounding. This is one area where compounded preparations fill a genuine gap in the approved product landscape.

Understanding what bioidentical hormones are made from and how they compare to synthetic alternatives provides essential context here — if you haven’t read What Are Bioidentical Hormones Made From?, that post is a strong foundation for this discussion.

FDA-Approved vs. Compounded BHRT: A Quick-Reference Comparison

Feature	FDA-Approved Bioidentical HRT	Compounded BHRT
Regulatory status	Full FDA approval	Not FDA-approved; regulated by state pharmacy boards
Clinical trial evidence	Required for approval	Not required for individual preparations
Manufacturing standards	FDA Current Good Manufacturing Practice (cGMP)	Varies; PCAB accreditation is voluntary best practice
Dose customization	Limited to available commercial strengths	Highly customizable
Hormone molecule	Bioidentical	Bioidentical
Insurance coverage	Often covered	Rarely covered
Endorsed by NAMS/Endocrine Society	Yes, as first-line option	Caution advised; not recommended over approved options when equivalent alternatives exist
Appropriate for hormone combinations not commercially available	No	Yes

This comparison makes the trade-offs visible. Neither column is uniformly superior. The right choice depends on a patient’s individual clinical picture, provider expertise, and access to quality pharmacy resources.

Frequently Asked Questions

Is BHRT FDA approved?

The answer depends on which type of BHRT you mean. Several FDA-approved prescription medications contain bioidentical hormones — including estradiol patches, gels, and progesterone capsules. However, custom-compounded BHRT, mixed to individual prescriptions at compounding pharmacies, is not FDA-approved. Compounded preparations are legal and widely used, but they have not undergone the clinical trials required for FDA approval and are regulated differently than commercial drug products.

What is the difference between compounded and FDA-approved bioidentical hormones?

FDA-approved bioidentical hormones are manufactured drugs that have passed rigorous clinical trials for safety, efficacy, and consistency. Compounded bioidentical hormones are custom-prepared by a licensed pharmacy for an individual patient. Compounded products are not FDA-approved, meaning their potency, sterility, and absorption have not been independently verified through the same standardized testing process. Both types use identical hormone molecules, but the oversight frameworks are very different.

Are compounded bioidentical hormones safe?

Compounded BHRT is widely used and many patients report positive outcomes, but the FDA has flagged concerns about quality control, inconsistent dosing, and unverified health claims made by some compounding providers. Safety depends heavily on the quality of the compounding pharmacy. Patients are generally advised to use pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) and to work with a knowledgeable prescribing provider.

Does FDA approval mean a hormone therapy is better or safer?

FDA approval means a product has been evaluated through a standardized process for safety, efficacy, and manufacturing consistency — which is a meaningful benchmark. It does not automatically mean it is the right choice for every patient, nor does the absence of FDA approval mean a compounded product is dangerous. Many clinicians use both approved and compounded options depending on a patient’s specific hormonal needs. The regulatory status is one factor among many to discuss with your provider.

Which FDA-approved products contain bioidentical hormones?

Several commonly prescribed hormone products contain bioidentical estradiol or progesterone and carry full FDA approval. These include estradiol patches (such as Vivelle-Dot and Climara), estradiol gels (Divigel, EstroGel), estradiol sprays (Evamist), vaginal estradiol preparations, and oral micronized progesterone (Prometrium). Testosterone products approved for men (such as AndroGel) also use bioidentical testosterone, though no testosterone product is currently FDA-approved specifically for women.

Why do some doctors prefer compounded BHRT over FDA-approved options?

Some clinicians prefer compounded BHRT because it allows dose customization that commercial products do not offer. For patients who need a very low dose, a specific delivery method, or a combination of hormones in a single preparation, compounding provides flexibility. However, major medical organizations including NAMS and the Endocrine Society generally recommend FDA-approved options as the first-line approach when they can meet the patient’s clinical needs.

Ready to Explore BHRT?

Understanding the regulatory landscape is the first step toward making informed choices about your hormone health — but it’s just the beginning. If you’re experiencing symptoms and trying to figure out where you stand, start with our free Hormone Symptom Checklist at /tools/hormone-symptom-checker/. It takes less than three minutes and gives you a clear picture of what you’re experiencing and what questions to bring to your provider.

Want research-backed guidance delivered to your inbox every week? Subscribe to the MyHormoneGuide free newsletter at /#newsletter for the latest on BHRT, hormone health research, and practical patient guidance — no hype, no spam, just clarity.

The content on this site is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any hormone therapy. Individual results vary.